E Chuang

Author PubWeight™ 25.13‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Molecular basis of T cell inactivation by CTLA-4. Science 1998 3.00
2 Regulation of surface and intracellular expression of CTLA4 on mouse T cells. J Immunol 1996 2.69
3 Do mussels take wooden steps to deep-sea vents? Nature 2000 2.32
4 A biomarker panel and psychological morbidity differentiates the irritable bowel syndrome from health and provides novel pathophysiological leads. Aliment Pharmacol Ther 2014 1.64
5 Structural analysis of CTLA-4 function in vivo. J Immunol 2000 1.61
6 High levels of glucose-6-phosphatase gene and protein expression reflect an adaptive response in proliferating liver and diabetes. J Clin Invest 1995 1.33
7 Randomised clinical trial: alosetron improves quality of life and reduces restriction of daily activities in women with severe diarrhoea-predominant IBS. Aliment Pharmacol Ther 2012 1.05
8 A phase II dose ranging, double-blind, placebo-controlled study of alicaforsen enema in subjects with acute exacerbation of mild to moderate left-sided ulcerative colitis. Aliment Pharmacol Ther 2006 0.97
9 Phase I-II study of vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer: evidence for vorinostat-induced tubulin acetylation and Hsp90 inhibition in vivo. Breast Cancer Res Treat 2011 0.93
10 Phase III study of cyclophosphamide, doxorubicin, and fluorouracil (CAF) plus leucovorin versus CAF for metastatic breast cancer: Cancer and Leukemia Group B 9140. J Clin Oncol 2003 0.92
11 Identification of the sites of interaction between c-Raf-1 and Ras-GTP. Oncogene 1995 0.92
12 Employment after a breast cancer diagnosis: a qualitative study of ethnically diverse urban women. J Community Health 2012 0.90
13 Tetrathiomolybdate-associated copper depletion decreases circulating endothelial progenitor cells in women with breast cancer at high risk of relapse. Ann Oncol 2013 0.89
14 An exploratory study of sunitinib plus paclitaxel as first-line treatment for patients with advanced breast cancer. Ann Oncol 2009 0.87
15 Differential induction of Fos protein and a Fos-related antigen following acute and repeated cocaine administration. Brain Res Mol Brain Res 1994 0.85
16 Long-term growth and development in children after home parental nutrition. J Pediatr 1998 0.85
17 Bioavailability and therapeutic activity of alicaforsen (ISIS 2302) administered as a rectal retention enema to subjects with active ulcerative colitis. Aliment Pharmacol Ther 2006 0.84
18 Gastric retention of zinc-based pennies: radiographic appearance and hazards. Radiology 1999 0.82
19 Compact, integrated dynamic holographic memory with refreshed holograms. Opt Lett 1997 0.78
20 Variable gene expression within human tyrosinemia type 1 liver may reflect region-specific dysplasia. Hepatology 1996 0.76
21 Repair of retinal detachment caused by cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome. Am J Ophthalmol 1992 0.75
22 Changes in the ultrastructural localization of mRNA for a circadian regulated protein. Mol Mar Biol Biotechnol 1996 0.75
23 Storage of 1000 holograms with use of a dual-wavelength method. Appl Opt 1997 0.75
24 Holographic data storage in a DX-center material. Opt Lett 1997 0.75
25 Long-term, successful maintenance of bilateral cytomegalovirus retinitis using exclusively local therapy. Arch Ophthalmol 1996 0.75
26 Interferon alfa-2a in the treatment of exudative age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 1993 0.75
27 Current management of pediatric inflammatory bowel disease. Semin Pediatr Surg 1999 0.75
28 Preadmission management of acute gastroenteritis in children. Med J Aust 1991 0.75